Hyliion Holdings reported Q2 results on August 12 with short sellers at their most aggressive positioning in months — and the post-earnings picture shows the bears aren't backing down.
Short interest is the headline. At 9.6% of the free float, the position has grown materially since the pre-earnings preview published earlier this week, when the figure sat at 8.8%. The single-day jump on August 11 was striking: shares short climbed 8.6% in one session, taking the one-week build to 9.1% and the one-month expansion to nearly 50%. In absolute terms, the short book has grown from roughly 10.8 million shares at the start of July to almost 16.9 million now — a sustained, deliberate accumulation rather than a reactive spike. The ORTEX short score of 61.9 ranks in just the 8th percentile of the universe, flagging this as a name where bear positioning is considered meaningful relative to peers.
The borrow market is conspicuously easy for a stock with this much short interest, which tells a different story about conviction. Availability runs at roughly 240% — meaning around two-and-a-half shares remain available to borrow for every one already lent out — well inside the normal range and far off the 52-week tightest reading of 67.6%. Cost to borrow has actually eased over the past week, falling to 0.47% from 0.61%, and is near the floor of its 30-day range. That combination — heavy short interest, plentiful borrow, and cheap financing — means bears face virtually no friction. There is no squeeze pressure in the lending market; shorts are comfortable. Options traders have been tracking the same cautious direction, with the put/call ratio at 0.175, modestly above its 20-day mean of 0.155 and near a one-year high of 0.200. Defensive positioning exists, but it's measured rather than alarmed.
Analysts are constructive on paper, though the coverage is thin and the latest data carries a caveat. Needham initiated in June with a Buy and a $9.00 target — well above the current $3.92 price. An earlier initiation from Johnson Rice set a $5.00 target. The consensus sits at Buy with a mean target of $7.00, implying substantial upside on those numbers. However, the analyst data is now approximately 63 days old, and the divergence between a $7.00 consensus target and a $3.92 share price warrants caution — either the targets are stale, or the market is pricing in a risk the two analysts are not. Factor scores are broadly weak: short score ranks in the 8th percentile, days-to-cover in the 28th, and the EPS surprise rank at 33 offers no bottom-up support for bullish positioning.
On ownership, the founder and CEO Thomas Healy holds 18.4% of shares — the dominant position in the cap table. BlackRock added meaningfully in its most recent filing, picking up 2.6 million shares to bring its stake to 6.4%. Vanguard Capital Management appears to have initiated a new position of 6.4 million shares as of June 30. But the insider picture has a different tone: on May 19 and 20, a cluster of C-suite executives — the CEO, CFO, CTO, Chief Commercial Officer, Chief Compliance Officer, and Chief Accounting Officer — all sold shares on the same two days. The individual amounts were small and the trades rated low significance, consistent with routine plan sales, but the breadth of the simultaneous selling across the entire leadership team is worth noting. The net insider position over the past 90 days remains marginally positive at around 217,000 shares and $572,000 in value, suggesting the sells were offset by other transactions, but the optics of six executives all selling into the same two-day window just before earnings is an angle institutional holders will have noticed.
With earnings now delivered, the next formal catalyst is the November 10 Q3 print. What to watch in the interim is whether the short position continues to build from here — a further climb above 10% of the float would signal bears are finding new reasons to press the stock — or whether the earnings results prompt any covering that tests the stock's ability to hold above the $3.92 close.
See the live data behind this article on ORTEX.
Open HYLN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
